rs11078398

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_030665.4(RAI1):​c.837G>A​(p.Gln279Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0053 ( 5 hom., cov: 0)
Exomes 𝑓: 0.0080 ( 32 hom. )
Failed GnomAD Quality Control

Consequence

RAI1
NM_030665.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 2.45

Publications

16 publications found
Variant links:
Genes affected
RAI1 (HGNC:9834): (retinoic acid induced 1) This gene is located within the Smith-Magenis syndrome region on chromosome 17. It is highly similar to its mouse counterpart and is expressed at high levels mainly in neuronal tissues. The protein encoded by this gene includes a polymorphic polyglutamine tract in the N-terminal domain. Expression of the mouse counterpart in neurons is induced by retinoic acid. This gene is associated with both the severity of the phenotype and the response to medication in schizophrenic patients. [provided by RefSeq, Jul 2008]
RAI1 Gene-Disease associations (from GenCC):
  • Smith-Magenis syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • Potocki-Lupski syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 17-17793785-G-A is Benign according to our data. Variant chr17-17793785-G-A is described in ClinVar as Benign. ClinVar VariationId is 96198.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.45 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.232 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RAI1NM_030665.4 linkc.837G>A p.Gln279Gln synonymous_variant Exon 3 of 6 ENST00000353383.6 NP_109590.3 Q7Z5J4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RAI1ENST00000353383.6 linkc.837G>A p.Gln279Gln synonymous_variant Exon 3 of 6 1 NM_030665.4 ENSP00000323074.4 Q7Z5J4-1
RAI1ENST00000395774.1 linkc.837G>A p.Gln279Gln synonymous_variant Exon 2 of 2 2 ENSP00000379120.1 A8MXE8

Frequencies

GnomAD3 genomes
AF:
0.00530
AC:
287
AN:
54134
Hom.:
5
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00253
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00558
Gnomad ASJ
AF:
0.00239
Gnomad EAS
AF:
0.315
Gnomad SAS
AF:
0.160
Gnomad FIN
AF:
0.000254
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00353
Gnomad OTH
AF:
0.00674
GnomAD2 exomes
AF:
0.0489
AC:
9588
AN:
195896
AF XY:
0.0451
show subpopulations
Gnomad AFR exome
AF:
0.0541
Gnomad AMR exome
AF:
0.0367
Gnomad ASJ exome
AF:
0.0208
Gnomad EAS exome
AF:
0.0812
Gnomad FIN exome
AF:
0.0864
Gnomad NFE exome
AF:
0.0375
Gnomad OTH exome
AF:
0.0390
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00796
AC:
4154
AN:
522176
Hom.:
32
Cov.:
0
AF XY:
0.00944
AC XY:
2402
AN XY:
254516
show subpopulations
African (AFR)
AF:
0.00315
AC:
20
AN:
6352
American (AMR)
AF:
0.0123
AC:
84
AN:
6850
Ashkenazi Jewish (ASJ)
AF:
0.00149
AC:
13
AN:
8720
East Asian (EAS)
AF:
0.169
AC:
143
AN:
848
South Asian (SAS)
AF:
0.163
AC:
1713
AN:
10490
European-Finnish (FIN)
AF:
0.00882
AC:
146
AN:
16552
Middle Eastern (MID)
AF:
0.0178
AC:
30
AN:
1682
European-Non Finnish (NFE)
AF:
0.00389
AC:
1754
AN:
451456
Other (OTH)
AF:
0.0131
AC:
251
AN:
19226
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.442
Heterozygous variant carriers
0
231
462
692
923
1154
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00532
AC:
288
AN:
54172
Hom.:
5
Cov.:
0
AF XY:
0.00601
AC XY:
154
AN XY:
25640
show subpopulations
African (AFR)
AF:
0.00252
AC:
34
AN:
13488
American (AMR)
AF:
0.00557
AC:
22
AN:
3948
Ashkenazi Jewish (ASJ)
AF:
0.00239
AC:
3
AN:
1256
East Asian (EAS)
AF:
0.315
AC:
34
AN:
108
South Asian (SAS)
AF:
0.162
AC:
84
AN:
520
European-Finnish (FIN)
AF:
0.000254
AC:
1
AN:
3936
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
116
European-Non Finnish (NFE)
AF:
0.00353
AC:
105
AN:
29734
Other (OTH)
AF:
0.00665
AC:
5
AN:
752
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
15
30
44
59
74
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.259
Hom.:
2043

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Mar 18, 2014
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 15, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Mar 11, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

RAI1-related disorder Benign:1
Jun 20, 2022
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.65
CADD
Benign
0.90
DANN
Benign
0.39
PhyloP100
2.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11078398; hg19: chr17-17697099; COSMIC: COSV55388938; COSMIC: COSV55388938; API